Association of deficient type II protein kinase A activity with aberrant nuclear translocation of the RII beta subunit in systemic lupus erythematosus T lymphocytes - PubMed (original) (raw)

Association of deficient type II protein kinase A activity with aberrant nuclear translocation of the RII beta subunit in systemic lupus erythematosus T lymphocytes

N Mishra et al. J Immunol. 2000.

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disorder of indeterminate etiology characterized by abnormal T cell signal transduction and altered T cell effector functions. We have previously observed a profound deficiency of total protein kinase A (PKA) phosphotransferase activity in SLE T cells. Here we examined whether reduced total PKA activity in SLE T cells is in part the result of deficient type II PKA (PKA-II) isozyme activity. The mean PKA-II activity in SLE T cells was 61% of normal control T cells. The prevalence of deficient PKA-II activity in 35 SLE subjects was 37%. Deficient isozyme activity was persistent over time and was unrelated to SLE disease activity. Reduced PKA-II activity was associated with spontaneous dissociation of the cytosolic RIIbeta2C2 holoenzyme and translocation of the regulatory (RIIbeta) subunit from the cytosol to the nucleus. Confocal immunofluorescence microscopy revealed that the RIIbeta subunit was present in approximately 60% of SLE T cell nuclei compared with only 2-3% of normal and disease controls. Quantification of nuclear RIIbeta subunit protein content by immunoprecipitation and immunoblotting demonstrated a 54% increase over normal T cell nuclei. Moreover, the RIIbeta subunit was retained in SLE T cell nuclei, failed to relocate to the cytosol, and was associated with a persistent deficiency of PKA-II activity. In conclusion, we describe a novel mechanism of deficient PKA-II isozyme activity due to aberrant nuclear translocation of the RIIbeta subunit and its retention in the nucleus in SLE T cells. Deficient PKA-II activity may contribute to impaired signaling in SLE T cells.

PubMed Disclaimer

Cited by

Persistent mitochondrial hyperpolarization, increased reactive oxygen intermediate production, and cytoplasmic alkalinization characterize altered IL-10 signaling in patients with systemic lupus erythematosus.
Gergely P Jr, Niland B, Gonchoroff N, Pullmann R Jr, Phillips PE, Perl A. Gergely P Jr, et al. J Immunol. 2002 Jul 15;169(2):1092-101. doi: 10.4049/jimmunol.169.2.1092. J Immunol. 2002. PMID: 12097418 Free PMC article.
Sex differences in brain protein expression and disease.
Wingo AP, Liu Y, Gerasimov ES, Vattathil SM, Liu J, Cutler DJ, Epstein MP, Blokland GAM, Thambisetty M, Troncoso JC, Duong DM, Bennett DA, Levey AI, Seyfried NT, Wingo TS. Wingo AP, et al. Nat Med. 2023 Sep;29(9):2224-2232. doi: 10.1038/s41591-023-02509-y. Epub 2023 Aug 31. Nat Med. 2023. PMID: 37653343 Free PMC article.
Abnormalities of T cell signaling in systemic lupus erythematosus.
Moulton VR, Tsokos GC. Moulton VR, et al. Arthritis Res Ther. 2011 Mar 17;13(2):207. doi: 10.1186/ar3251. Arthritis Res Ther. 2011. PMID: 21457530 Free PMC article. Review.
Trichostatin A reverses skewed expression of CD154, interleukin-10, and interferon-gamma gene and protein expression in lupus T cells.
Mishra N, Brown DR, Olorenshaw IM, Kammer GM. Mishra N, et al. Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2628-33. doi: 10.1073/pnas.051507098. Epub 2001 Feb 20. Proc Natl Acad Sci U S A. 2001. PMID: 11226290 Free PMC article.
T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity.
Moulton VR, Tsokos GC. Moulton VR, et al. J Clin Invest. 2015 Jun;125(6):2220-7. doi: 10.1172/JCI78087. Epub 2015 May 11. J Clin Invest. 2015. PMID: 25961450 Free PMC article. Review.

Association of deficient type II protein kinase A activity with aberrant nuclear translocation of the RII beta subunit in systemic lupus erythematosus T lymphocytes - PubMed (original) (raw)